Literature DB >> 21103666

Rivaroxaban and false positive lupus anticoagulant testing.

Eileen Merriman, Zane Kaplan, Jenny Butler, Erica Malan, Eng Gan, Huyen Tran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21103666     DOI： 10.1160/TH10-08-0511

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

Review 1.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

Review 2.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

Review 3.  Laboratory diagnosis of the lupus anticoagulant.

Authors:  Thomas L Ortel
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 4.  Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.

Authors:  Virginie Dufrost; Jessie Risse; Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 5.  Rivaroxaban: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Authors:  Natalie J Carter; Greg L Plosker
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

6.  Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.

Authors:  Flavio Signorelli; Felipe Nogueira; Vinicius Domingues; Henrique Ataide Mariz; Roger A Levy
Journal:  Clin Rheumatol       Date:  2015-07-30       Impact factor: 2.980

Review 7.  The antiphospholipid syndrome: still an enigma.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

Review 8.  Use of new oral anticoagulants in antiphospholipid syndrome.

Authors:  Deepa Jayakody Arachchillage; Hannah Cohen
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

Review 9.  Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations.

Authors:  Jonathan Douxfils; Helen Mani; Valentine Minet; Bérangère Devalet; Bernard Chatelain; Jean-Michel Dogné; François Mullier
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

10.  Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series.

Authors:  Hareton Teixeira Vechi; Lucas Rodrigues Maia; Manoella do Monte Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-09-04       Impact factor: 1.846
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.